US 12281321
Frataxin expression constructs having engineered promoters and methods of use thereof
granted A61KA61K47/02A61K47/10
Quick answer
US patent 12281321 (Frataxin expression constructs having engineered promoters and methods of use thereof) held by VOYAGER THERAPEUTICS, INC. expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VOYAGER THERAPEUTICS, INC.
- Grant date
- Tue Apr 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 42
- CPC classes
- A61K, A61K47/02, A61K47/10, A61K48/005, A61K48/0058